Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Chemically Competent Cells Market by Type (Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells, Expression Competent Cells), By Application (Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Chemically Competent Cells Market by Type (Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells, Expression Competent Cells), By Application (Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 168282 3300 Medical Devices & Consumables 377 245 Pages 4.7 (43)
                                          

Market Overview:


The global chemically competent cells market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for genetically modified organisms (GMOs) and rising research and development expenditure on biotechnology products. The chemically competent cells market can be segmented on the basis of type, application, and region. On the basis of type, the market can be divided into cloned competent cells, Agrobacterium tumefaciens competent cells, expression competent cells, and others. Cloned incompetent cells are expected to account for a major share of the global chemically competent cell market during the forecast period owing to their high efficiency in cloning operations. On the basis of application, subcloning & routine cloning is projected to hold a dominant share in terms of revenue during 2018-2030 owing its widespread use across various industries such as pharmaceuticals & biotechnology and agriculture & animal husbandry.


Global Chemically Competent Cells Industry Outlook


Product Definition:


Chemically competent cells are bacteria that have been treated with a special chemical to make them more receptive to genetic engineering. The treatment causes the cells to temporarily become permeable, which allows DNA to enter and be integrated into the bacterial chromosome.


Cloned Competent Cells:


Cloned competent cells are the ones that have been extracted from a living organism and then engineered to become useful in laboratory experiments. These cells possess all the necessary attributes to carry out their assigned task efficiently, which includes growing, divide & die when appropriate and release chemicals as per requirement. Cloning is an important step in any biotechnology process; it's used for research purposes mainly for cell culture workflows but also finds its use in other applications such as protein expression & transfection protocols.


Agrobacterium tumefaciens Competent Cells:


Agrobacterium tumefaciens competent cells are also known as A.tumefaciens cell wall deficient (CWD) or Wall-less bacteria. These cells are used in the production of genetically modified plants and they help in increasing the efficiency of plant transformation procedures by enabling efficient gene transfer to a variety of host plants.


Agrobacterium tumefaciens Competent Cells.


Application Insights:


The routine cloning and subcloning applications are expected to witness lucrative growth over the forecast period. The routine cloning procedures are used for DNA or protein synthesis in a laboratory setting. Routinely, chemically competent cells are used for subcloning as they provide higher efficiency in bacterial transformation and expression of genes compared to traditional methods. Moreover, these products enable rapid screening of libraries by PCR or Southern Blotting which further boosts their demand in this segment.


Rise in demand for toxic/unstable Dna Cloning is also anticipated to drive the market over the forecast period owing to its high success rate and low cost per experiment when compared with conventional techniques such as transgenic plants or animals (using viruses).


Regional Analysis:


North America accounted for the largest share of over 40.0% in 2017 owing to the presence of a substantial number of chemical companies involved in R&D activities. Moreover, these companies are engaged in commercializing their products at a relatively higher price range which is further expected to boost adoption rate for this technique within this region.


Asia Pacific is anticipated to be the fastest growing market with a CAGR close to 13.0% during the forecast period due to increasing awareness about advanced technologies among farmers and researchers from developing economies such as India and China along with Japan and Korea, etc., especially after some notable technological advancements were observed recently by these countries through research projects supported by organizations like Department for International Development (DFID), UK; Wellcome Trust; Indian Council Of Medical Research (ICMR), India; National Centre For Cell Science, Japan etc.


Growth Factors:


  • Increasing demand for genetically modified crops
  • Growing research and development in the field of biotechnology
  • Rising number of biotechnology and pharmaceutical companies
  • Technological advancements in the field of molecular biology and recombinant DNA technology
  • Increasing application areas of chemically competent cells

Scope Of The Report

Report Attributes

Report Details

Report Title

Chemically Competent Cells Market Research Report

By Type

Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells, Expression Competent Cells

By Application

Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)

By Companies

Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

245

Number of Tables & Figures

172

Customization Available

Yes, the report can be customized as per your need.


Global Chemically Competent Cells Market Report Segments:

The global Chemically Competent Cells market is segmented on the basis of:

Types

Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells, Expression Competent Cells

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Merck KGaA
  2. Thermo Fisher Scientific
  3. Agilent Technologies
  4. Takara Bio
  5. Promega Corporation
  6. Beijing TransGen Biotech
  7. GeneScript Corporation
  8. Yeastern Biotech
  9. New England Biolabs
  10. QIAGEN N.V.
  11. OriGene Technologies
  12. Lucigen
  13. Zymo Research
  14. Bio-Rad Laboratories
  15. Bioline
  16. Delphi Genetics
  17. IBA GmBH
  18. Cell Applications
  19. BioDynamics Laboratory
  20. Scarab Genomics

Global Chemically Competent Cells Market Overview


Highlights of The Chemically Competent Cells Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Cloned Competent Cells
    2. Agrobacterium tumefaciens Competent Cells
    3. Expression Competent Cells
  1. By Application:

    1. Subcloning & Routine Cloning
    2. Phage Display Library Construction
    3. Toxic/Unstable Dna Cloning
    4. High-Throughput Cloning
    5. Protein Expression
    6. Mutagenesis
    7. Single-Stranded Dna Production
    8. Bacmid creation
    9. Cre-lox recombination (PIR1/PIR2)
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Chemically Competent Cells Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Chemically Competent Cells Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Chemically competent cells are cells that can take up and use foreign chemicals.

Some of the major companies in the chemically competent cells market are Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., OriGene Technologies, Lucigen, Zymo Research, Bio-Rad Laboratories, Bioline, Delphi Genetics, IBA GmBH, Cell Applications, BioDynamics Laboratory, Scarab Genomics.

The chemically competent cells market is expected to register a CAGR of 10.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Chemically Competent Cells Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Chemically Competent Cells Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Chemically Competent Cells Market - Supply Chain
   4.5. Global Chemically Competent Cells Market Forecast
      4.5.1. Chemically Competent Cells Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Chemically Competent Cells Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Chemically Competent Cells Market Absolute $ Opportunity

5. Global Chemically Competent Cells Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Chemically Competent Cells Market Size and Volume Forecast by Type
      5.3.1. Cloned Competent Cells
      5.3.2. Agrobacterium tumefaciens Competent Cells
      5.3.3. Expression Competent Cells
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Chemically Competent Cells Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Chemically Competent Cells Market Size and Volume Forecast by Application
      6.3.1. Subcloning & Routine Cloning
      6.3.2. Phage Display Library Construction
      6.3.3. Toxic/Unstable Dna Cloning
      6.3.4. High-Throughput Cloning
      6.3.5. Protein Expression
      6.3.6. Mutagenesis
      6.3.7. Single-Stranded Dna Production
      6.3.8. Bacmid creation
      6.3.9. Cre-lox recombination (PIR1/PIR2)
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Chemically Competent Cells Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Chemically Competent Cells Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Chemically Competent Cells Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Chemically Competent Cells Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Chemically Competent Cells Demand Share Forecast, 2019-2026

9. North America Chemically Competent Cells Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Chemically Competent Cells Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Chemically Competent Cells Market Size and Volume Forecast by Application
      9.4.1. Subcloning & Routine Cloning
      9.4.2. Phage Display Library Construction
      9.4.3. Toxic/Unstable Dna Cloning
      9.4.4. High-Throughput Cloning
      9.4.5. Protein Expression
      9.4.6. Mutagenesis
      9.4.7. Single-Stranded Dna Production
      9.4.8. Bacmid creation
      9.4.9. Cre-lox recombination (PIR1/PIR2)
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Chemically Competent Cells Market Size and Volume Forecast by Type
      9.7.1. Cloned Competent Cells
      9.7.2. Agrobacterium tumefaciens Competent Cells
      9.7.3. Expression Competent Cells
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Chemically Competent Cells Demand Share Forecast, 2019-2026

10. Latin America Chemically Competent Cells Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Chemically Competent Cells Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Chemically Competent Cells Market Size and Volume Forecast by Application
      10.4.1. Subcloning & Routine Cloning
      10.4.2. Phage Display Library Construction
      10.4.3. Toxic/Unstable Dna Cloning
      10.4.4. High-Throughput Cloning
      10.4.5. Protein Expression
      10.4.6. Mutagenesis
      10.4.7. Single-Stranded Dna Production
      10.4.8. Bacmid creation
      10.4.9. Cre-lox recombination (PIR1/PIR2)
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Chemically Competent Cells Market Size and Volume Forecast by Type
      10.7.1. Cloned Competent Cells
      10.7.2. Agrobacterium tumefaciens Competent Cells
      10.7.3. Expression Competent Cells
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Chemically Competent Cells Demand Share Forecast, 2019-2026

11. Europe Chemically Competent Cells Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Chemically Competent Cells Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Chemically Competent Cells Market Size and Volume Forecast by Application
      11.4.1. Subcloning & Routine Cloning
      11.4.2. Phage Display Library Construction
      11.4.3. Toxic/Unstable Dna Cloning
      11.4.4. High-Throughput Cloning
      11.4.5. Protein Expression
      11.4.6. Mutagenesis
      11.4.7. Single-Stranded Dna Production
      11.4.8. Bacmid creation
      11.4.9. Cre-lox recombination (PIR1/PIR2)
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projecions by Application
   11.7. Europe Chemically Competent Cells Market Size and Volume Forecast by Type
      11.7.1. Cloned Competent Cells
      11.7.2. Agrobacterium tumefaciens Competent Cells
      11.7.3. Expression Competent Cells
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Chemically Competent Cells Demand Share, 2019-2026

12. Asia Pacific Chemically Competent Cells Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Chemically Competent Cells Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Chemically Competent Cells Market Size and Volume Forecast by Application
      12.4.1. Subcloning & Routine Cloning
      12.4.2. Phage Display Library Construction
      12.4.3. Toxic/Unstable Dna Cloning
      12.4.4. High-Throughput Cloning
      12.4.5. Protein Expression
      12.4.6. Mutagenesis
      12.4.7. Single-Stranded Dna Production
      12.4.8. Bacmid creation
      12.4.9. Cre-lox recombination (PIR1/PIR2)
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Chemically Competent Cells Market Size and Volume Forecast by Type
      12.7.1. Cloned Competent Cells
      12.7.2. Agrobacterium tumefaciens Competent Cells
      12.7.3. Expression Competent Cells
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Chemically Competent Cells Demand Share, 2019-2026

13. Middle East & Africa Chemically Competent Cells Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Chemically Competent Cells Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Chemically Competent Cells Market Size and Volume Forecast by Application
      13.4.1. Subcloning & Routine Cloning
      13.4.2. Phage Display Library Construction
      13.4.3. Toxic/Unstable Dna Cloning
      13.4.4. High-Throughput Cloning
      13.4.5. Protein Expression
      13.4.6. Mutagenesis
      13.4.7. Single-Stranded Dna Production
      13.4.8. Bacmid creation
      13.4.9. Cre-lox recombination (PIR1/PIR2)
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Chemically Competent Cells Market Size and Volume Forecast by Type
      13.7.1. Cloned Competent Cells
      13.7.2. Agrobacterium tumefaciens Competent Cells
      13.7.3. Expression Competent Cells
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Chemically Competent Cells Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Chemically Competent Cells Market: Market Share Analysis
   14.2. Chemically Competent Cells Distributors and Customers
   14.3. Chemically Competent Cells Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Merck KGaA
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Thermo Fisher Scientific
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Agilent Technologies
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Takara Bio
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Promega Corporation
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Beijing TransGen Biotech
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. GeneScript Corporation
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Yeastern Biotech
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. New England Biolabs
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. QIAGEN N.V.
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. OriGene Technologies
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Lucigen
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Zymo Research
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Bio-Rad Laboratories
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Bioline
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Delphi Genetics
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. IBA GmBH
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. Cell Applications
         14.4.18.1.&nbs

Our Trusted Clients

Contact Us